Skip to main navigation Skip to search Skip to main content

Tipranavir (TPV) genotypic Inhibitory Quotient (gIQ) predicts virological responce at 24 weeks to TPV-based salvage regimens

  • Stefano BONORA
  • , Daniel GONZALEZ DE REQUENA
  • , Andrea CALCAGNO
  • , Milia MG
  • , ANTONIO D'AVOLIO
  • , Mauro SCIANDRA
  • , Silvia GARAZZINO
  • , MARCO SICCARDI
  • , Alessandro SINICCO
  • , Giovanni DI PERRI

Research output: Contribution to conferencePaper

Original languageEnglish
Pages---
Publication statusPublished - 2006
Event7th International workshop on Clinical Pharmacology of HIV Therapy - Lisbon, Portugal
Duration: 1 Jan 2006 → …

Conference

Conference7th International workshop on Clinical Pharmacology of HIV Therapy
CityLisbon, Portugal
Period1/01/06 → …

Cite this